Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Malignant Melanoma

Free Subscription Articles published in Ann Surg Retrieve available abstracts of 6 articles: HTML format

Single Articles

February 2023
1. MARIANI P, Bidard FC, Rampanou A, Houy A, et al
   Circulating tumor DNA as a Prognostic Factor in Patients with Resectable Hepatic Metastases of Uveal Melanoma.
   Ann Surg. 2023 Feb 27. doi: 10.1097/SLA.0000000000005822.
   PubMed     Abstract available
   
   
   November 2022
2. MENEVEAU MO, Vavolizza RD, Mohammad A, Kumar P, et al
   A Step Toward Personalized Surgical Decision Making: Machine Learning Predicts One Versus Numerous Melanoma Lymph Node Metastases Using RNA-Sequencing.
   Ann Surg. 2022 Nov 25. doi: 10.1097/SLA.0000000000005761.
   PubMed     Abstract available
   
   
   July 2022
3. MONCRIEFF MD, Bastiaannet E, Underwood B, Francken AB, et al
   Follow-up Schedule for Patients with Sentinel Node Negative Cutaneous Melanoma: an International Phase III Randomised Clinical Trial.
   Ann Surg. 2022 Jul 22. pii: 00000658-990000000-00177.
   PubMed     Abstract available
   
   
   
4. RHODIN KE, Gaughan EM, Raman V, Salama AK, et al
   Multicenter Experience with Neoadjuvant Therapy in Melanoma Highlights Heterogeneity in Contemporary Practice.
   Ann Surg. 2022 Jul 7. pii: 00000658-990000000-00089.
   PubMed     Abstract available
   
   
   January 2022
5. BROMAN KK, Hughes TM, Bredbeck BC, Sun J, et al
   International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node Positive Melanoma at Major Referral Centers.
   Ann Surg. 2022 Jan 27. pii: 00000658-900000000-93085.
   PubMed     Abstract available
   
   
   April 2021
6. BLANKENSTEIN SA, Rohaan MW, Klop WMC, van der Hiel B, et al
   Neoadjuvant Cytoreductive Treatment with BRAF/MEK Inhibition of prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single Arm, Open-label Phase II Trial.
   Ann Surg. 2021 Apr 9. pii: 00000658-900000000-93605.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: